3548
J. Priego et al. / Tetrahedron: Asymmetry 15 (2004) 3545–3549
22.0, 48.9, 116.6, 116.6, 117.4, 126.1, 127.1, 127.4, 128.8,
132.2, 143.4, 148.8, 168.4. Anal. Calcd for C15H16N2O:
C, 74.22;H, 6.78;N, 11.32. Found: C, 74.97;H, 6.71;
N, 11.66.
d, J = 12.0Hz), 4.12 (1H, d, J = 12.0Hz), 6.06 (1H,
c, J = 7.2Hz), 7.20–7.40 (5H, m); 13C NMR (50MHz,
CDCl3) d 16.0, 22.3, 24.4, 26.1, 29.9, 43.3, 48.8, 51.6,
56.8, 127.2, 127.5, 128.6, 140.1, 171.1. Anal. Calcd for
C16H22N2O: C, 74.42;H, 8.53;N, 10.85. Found: C,
73.86;H, 8.56;N, 10.77. X-ray crystallographic struc-
ture in Figure 2.16
4.1.2.
3,4-Dihydro-3-[(S)-a-methylbenzyl]-4-quinazol-
inone 2. A solution of the aminobenzamide 1 (1equiv,
1.0g, 4.16mmol) in toluene (20mL) was treated with tri-
ethyl orthoformate (1.1equiv, 0.7mL, 4.58mmol), p-tolu-
enesulfonic acid monohydrate (0.1g) and the reaction
mixture heated to 40ꢁC for 2h. The organic layer was
concentrated under reduced pressure. The crude product
was purified by FC (hexane–ethyl acetate 70:30 !
4.2.3. (4aR,8aR)-3-[(S)-a-Methylbenzyl]-1,2,4a,5,6,7,8,
8a-octahydroquinazolin-4-one 5. 0.093g (10% yield) as
24
D
a white crystals, mp 107–109 ꢁC; ½a ¼ ꢀ83:7 (c 1.0,
1
MeOH); H NMR (200MHz CDCl3) d 1.09–1.33 (5H,
m), 1.52 (3H, d, J = 7.2Hz), 1.79–1.88 (3H, m), 1.93–
1.96 (1H, m), 2.46–2.49 (1H, m), 2.57 (1H, ddd,
J = 3.6Hz, J = J = 11.2Hz), 3.87 (1H, d, J = 11.2Hz),
4.25 (1H, d, J = 11.6Hz), 6.07 (1H, q, J = 7.6Hz),
7.23–7.36 (5H, m); 13C NMR (50MHz, CDCl3) d 16.0,
25.5, 26.3, 26.5, 33.9, 49.0, 49.3, 57.5, 56.7, 127.3,
127.4, 128.4, 140.7, 170.1. Anal. Calcd for C16H22N2O:
C, 74.42;H, 8.53;N, 10.85. Found: C, 74.00;H, 8.60;
N, 10.54. X-ray crystallographic structure in Figure 3.16
50:50) to produce 1.01g (96% yield) of 2, as an oil:
24
½a ¼ ꢀ277:0 (c 0.50, MeOH), 1H NMR (200MHz,
D
CDCl3) d 1.85 (3H, d, J = 7.0Hz), 6.38 (1H, q, J =
6.8Hz), 7.38 (5H, m), 7.48 (1H, dd, Jmeta = 1.8Hz,
Jortho = 7.6Hz), 7.65–7.80 (2H, m), 7.94 (1H, s), 8.36
(1H, dd, Jmeta = 1.6Hz, Jortho = 8.0Hz); 13C NMR
(50MHz, CDCl3) d 19.3, 51.9, 122.0, 127.2, 127.4,
127.5, 127.5, 128.5, 129.2, 134.4, 139.6, 144.6, 147.7,
161.0. Anal. Calcd for C16H14N2O: C, 76.78;H, 5.64;
N, 11.19. Found: C, 76.45;H, 5.70;N, 10.97.
4.3. General procedure for epimerization of cis-
octahydroquinazolinones
4.2. General procedure for the hydrogenation of quinaz-
olinone 2
A
solution of cis-octahydroquinazolinone (0.2g,
0.78mmol) in 10mL anhydrous THF was treated with
t-BuOK (0.087g, 0.78mmol) and heated at reflux for
6h. The mixture was then evaporated to afford the crude
product. The residue was purified by FC (hexane/ethyl
acetate/isopropyl alcohol 6:3.6:0.4).
Quinazolinone 2 (1.0g, 4.0mmol), 10mL of acetic acid,
two drops of sulfuric acid, 0.02g of PtO2 catalyst and
activated charcoal (0.8g) were combined, and the mix-
ture shaken at room temperature in a Parr hydrogenator
for 30min under 60psi of hydrogen. The catalyst was fil-
tered through Celite and the filtrate neutralized with
NaOH 30% aq until it reached pH10–12. The resulting
cloudy, aqueous solution, was extracted with CH2Cl2
(3 · 15mL). The combined organic layers were dried
over MgSO4 and the solvent removed to obtain a pale
yellow oil. Octahydroquinazolinones 3–5 were purified
by FC [hexane/ethyl acetate/isopropyl alcohol
(6:3.6:0.4)].
4.3.1. (4aR,8aR)-3-[(S)-a-Methylbenzyl]-1,2,4a,5,6,7,8,
8a-octahydroquinazolin-4-one 5. 0.16g (80% yield) as
white crystals. The spectroscopy data were found to be
identical with those already presented.
4.3.2. (4aS,8aS)-3-[(S)-a-Methylbenzyl]-1,2,4a,5,6,7,8,
8a-octahydroquinazolin-4-one 6. 0.16g (80% yield) as
24
D
white crystals, mp 128–130ꢁC; ½a ¼ ꢀ87:0 (c 1.0,
1
MeOH); H NMR (200MHz, CDCl3) d 1.10–1.29 (4H,
m), 1.52 (3H, d, J = 7.2Hz), 1.77–1.92 (4H, m), 1.77–
1.92 (1H, m), 2.42–2.49(1H, m), 2.42–2.49 (1H, m),
3.78 (1H, d, J = 12.0Hz), 4.10 (1H, d, J = 12.0Hz),
6.03 (1H, q, J = 7.2Hz), 7.24–7.35 (5H, m); 13C NMR
(50MHz, CDCl3) d 16.0, 25.4, 26.1, 26.6, 34.1, 49.0,
49.0, 57.0, 57.7, 127.4, 127.4, 128.6, 140.1, 170.1. Anal.
Calcd for C16H22N2O: C, 74.42;H, 8.53;N, 10.85.
Found: C, 74.23;H, 8.56;N, 10.76.
4.2.1. (4aS,8aR)-3-[(S)-a-Methylbenzyl]-1,2,4a,5,6,7,8,8a-
octahydroquinazolin-4-one 3. 0.558g (60% yield) as a
24
D
white crystals, mp 113–115ꢁC; ½a ¼ ꢀ112:8 (c
1
1.0, MeOH), H NMR (200MHz, CDCl3) d 1.32–1.40
(2H, m), 1.51 (3H, d, J = 7.6Hz), 1.54–1.77 (6H, m),
1.90–1.97 (1H, m), 2.44 (1H, dt, J = J = 4.4Hz,
J = 14.8Hz), 3.17 (1H, dd, J = J = 4.4Hz), 3.83 (1H, d,
J = 11.6Hz), 4.17 (1H, d, J = 12.0Hz), 6.06 (1H, q,
J = 7.2Hz), 7.25–7.37 (5H, m); 13C NMR (50MHz,
CDCl3) d 15.8, 21.6, 24.7, 26.3, 30.3, 43.1, 48.4, 51.7,
56.9, 127.3, 127.5, 128.7, 140.7, 171.6. Anal. Calcd for
C16H22N2O: C, 74.42;H, 8.53;N, 10.85. Found: C,
74.51;H, 8.64;N, 10.71. X-ray crystallographic struc-
ture in Figure 2.16
4.4. General procedure of the hydrolysis of the cis- and
trans-octahydroquinazolinones
A suspension of 0.1g (0.39mmol) of the adduct in 10mL
of 6M HCl was heated in a sealed ampoule to 110–
115ꢁC for 6h. The solution was then allowed to cool
to ambient temperature. The residue was evaporated
at reduced pressure, and treated with a 10% solution
of NaOH (pH P10). The aqueous phase was extracted
with three 10mL portions of CH2Cl2. The combined ex-
tracts were dried over MgSO4, filtered and evaporated
to give the crude chiral auxiliary [(S)-a-methylbenzyl-
amine]. The aqueous phase was then treated with a
4.2.2. (4aR,8aS)-3-[(S)-a-Methylbenzyl]-1,2,4a,5,6,7,8,-
8a-octahydroquinazolin-4-one 4. 0.279g (30% yield) as
24
D
a white crystals, mp 128–130ꢁC; ½a ¼ ꢀ126:0 (c 1.0,
1
MeOH), H NMR (200MHz, CDCl3) d 1.44–1.48 (2H,
m), 1.53 (3H, d, J = 7.2Hz), 1.61–1.64 (6H, m),
1.82–1.86 (1H, m), 2.46 (1H, dt, J = J = 4.8Hz,
J = 13.6Hz), 3.09 (1H, dd, J = J = 4.4Hz), 3.75 (1H,